Septodont

Cook-Waite Marcaine 0.5 % Bupivacaine with Epinephrine 1:200,000 Box of 50 - 1.7 mL. Local dental anesthesia by infiltration or nerve block injections in adults. Features & benefits Anesthesia may last two to three times longer than lidocaine and mepivacaine for dental use, in many patients up to 7 hours.  Onset of action is usually 2 to 10 minutes.  No-methylparaben formulation to avoid allergic reactions on sensitive patients.  100 percent latex free components to help reduce allergic responses.  Terminal sterilization of product/cartridges for safe use.  Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.  Cartridges packed 10 to a blister tray to avoid glass-to-glass contact, hence reducing breakage.   Presentation Item# 99184 – Box containing 5 blisters of 10 x 1.7 ml glass cartridges. Manufacturer # 99184 Brand Marcaine™ with Epinephrine Manufacturer Septodont Country of Origin Canada Application Local Anesthetic Container Type Dental Cartridge Dosage Form Injection Generic Drug Name Bupivacaine HCl NDC Number 00362055705 Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 0.5% - 1:200,000 Type Infiltration and Nerve Block UNSPSC Code 51271622 Volume 1.8 mL  The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If the item is subject to FDA regulation, We will verify your status as an authorized purchaser of this item before shipping the item.

Read more less

Ideal osteogenic matrix: designed through a special manufacturing process Fully synthetic Sterile and Fully resorbable. Hydroxyapatite & ß-Tricalcium phosphate are both fully resorbable This micro & macroporous structure mimics human bone Offers a high success rate with no risk of disease associated Will gradually generate new natural bone Biphasic formulations associating the very bioactive ß-Tricalcium Phosphate and the stable Hydroxyapatite that allows resorption at the right pace which leads in the creation of a new strong and qualitative bone. Two formulations available allowing you to manage the pace of your bone grafting procedures A proprietary micro and macroporous structure setting for an appropriate scaffold and allowing cellular colonization Bioactive and osteoconductive material providing a matrix for new bone growth Indications RTR+ is a bone graft material intended to be used to reconstruct bony loss or bone gaps in maxillofacial applications: following tooth extractions following intrabony/periodontal/peri-implants defects ridge augmentations sinus lifts cystic cavity fillings Presentation Item #01S0540 – R.T.R.+ 40/60 (40% β-Tricalcium Phosphate / 60% Hydroxyapatite) - One 0.5cc syringe

Read more less

RTR+ is a bone graft material intended to be used to reconstruct bony loss or bone gaps in maxillofacial applications: following tooth extractions following intrabony/periodontal/peri-implants defects ridge augmentations sinus lifts cystic cavity fillings Features & benefits Ideal osteogenic matrix: designed through a special manufacturing process Fully synthetic Sterile and Fully resorbable. Hydroxyapatite & ß-Tricalcium phosphate are both fully resorbable This micro & macroporous structure mimics human bone Offers a high success rate with no risk of disease associated Will gradually generate new natural bone Biphasic formulations associate the very bioactive ß-Tricalcium Phosphate and the stable Hydroxyapatite that allows resorption at the right pace which leads in the creation of a new strong and qualitative bone. Two formulations available allowing you to manage the pace of your bone grafting procedures A proprietary micro and macroporous structure setting for an appropriate scaffold and allowing cellular colonization Bioactive and osteoconductive material provides a matrix for new bone growth Presentation Item #01S0530 – R.T.R.+ 80/20 (80% β-Tricalcium Phosphate / 20% Hydroxyapatite) - One 0.5cc syringe

Read more less